Medical company Intuitive Surgical (ISRG.US), which is responsible for, among other things, the production of the innovative da Vinci surgical robots, is gaining nearly 9% on the stock market today, after the company's financial results for the third quarter of this year came in well above market expectations.
Highlights from the Q3 report:
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app- Adjusted earnings per share: $1.84 (estimate $1.64); +26% y/y
- Revenues: $2.04 billion (estimate $2 billion); +17% y/y
- Revenue from instruments and accessories: $1.26 billion (estimate $1.24 billion); +18% y/y
- Systems revenue: $445 million (vs. $379 million y/y); +17% y/y
Operating indicators:
- da Vinci procedures worldwide: +15% y/y
- Installed base of da Vinci surgical systems: 9539 systems (vs. 8285 y/y); +15%
- New da Vinci system deployments: 379 (vs. 312 y/y)
- da Vinci 5 systems: 110 units
- Operating leases: 220 systems, including 141 under usage-based leases
Business updates:
- Regulatory approval: received approval in South Korea for da Vinci 5 surgical system for multiple procedures (urology, thoracic, gynecological, etc.).
Cash and capital structure:
- Cash, cash equivalents and investments: $8.31 billion (up $628 million quarter-on-quarter)
The company's shares rocketed to new highs after the release of strong quarterly results. Source: xStation
